© Copyright 2026 American Medical Association. All rights reserved.
Clostridium difficile toxin (C. difficile) is a spore-forming, gram-positive, anaerobic bacillus known for producing two significant exotoxins, namely toxin A and toxin B. The detection of C. difficile toxin A is crucial in diagnosing infections, particularly in patients who are undergoing antibiotic treatment and exhibit symptoms of antibiotic-associated diarrhea. This bacterium is notorious for causing severe gastrointestinal conditions, including pseudomembranous colitis, toxic megacolon, perforations of the colon, and even sepsis, which can be life-threatening. The testing process involves obtaining a fecal specimen from the patient, which is then analyzed using a test kit designed for rapid chromatographic immunoassay. This immunoassay method allows for the quick detection of the C. difficile toxin A in the stool sample. The test kit employs a series of reagents that specifically target the C. difficile antigen. The presence of the toxin is indicated by a color change on the test strip or other testing platform, where a test line or dot will change color if the toxin is present, alongside a second control line or dot that confirms the test's validity. This method provides a rapid and effective means of diagnosing C. difficile infections, facilitating timely treatment and management of the condition.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.